France· FR:69357111
EFFALA 8 mg, emplâtre médicamenteux
A medicinal product containing chlorhydrate de l'acide 5-aminolévulinique, registered in France by PHOTONAMIC (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE L'ACIDE 5-AMINOLÉVULINIQUE
- Manufacturer
- PHOTONAMIC (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009397996431 sachet(s) papier polyéthylène basse densité (PEBD) aluminium copolymère d'éthylène de 4 emplâtre(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de l'acide 5-aminolévulinique in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAlacarephotonamic GmbH & Co. KG
- IrelandAlacare 8 mg medicated plasterPhotonamic GmbH & Co. KG
- NetherlandsAlacare 8 mg pleister voor cutaan gebruikPhotonamic GmbH & Co. KG
- United StatesAMELUZBiofrontera Inc.
- CzechiaALACAREPhotonamic GmbH & Co. KG, Pinneberg
- United KingdomAlacare 8mg medicated plastersmedac UK
- SwitzerlandAlacare
- NorwayAmeluzBiofrontera Bioscience
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Alacare
- Belgium · Effala
- Czechia · Alacare
- Germany · Alacare
- Denmark · Alacare
- Finland · Alacare
- United Kingdom (Northern Ireland) · Alacare
- Ireland · Alacare
- Iceland · Ameluz, Gliolan
- Italy · Alacare
- Liechtenstein · Ameluz, Gliolan
- Netherlands · Alacare
- Norway · Alacare, Ameluz
- Poland · Alacare
- Portugal · Alacare
- Sweden · Alacare
- Slovakia · Alacare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac4c7880-b165-477a-b53a-42b82d3226f8 GET /v1/drugs/ac4c7880-b165-477a-b53a-42b82d3226f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69357111",
"date_amm": "2010-02-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE L'ACIDE 5-AMINOLÉVULINIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "emplâtre médicamenteux(se)",
"voies_administration": "cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de l'acide 5-aminolévulinique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.